Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Ilja DubinskiSusanne Bechtold Dalla-PozzaMartin BidlingmaierNicole ReischHeinrich SchmidtPublished in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
Our data do not support the use of RCT schemes for GC replacement in children with CAH due to lack of benefits and unknown long-term risks.